Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06431347
Status
Recruiting

Conditions

  • Transplant and Cell Therapy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Social Determinants of Health Questionnaire — BEHAVIORAL
    Participants will also complete a questionnaire about financial barriers to care within the past year, including income bracket and difficulty affording cost-of-living or medical expenses.

Study Details

To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.

Key Dates

Start date
Jun 17, 2024
Status verified
Mar 2026
Primary completion
Jun 1, 2027
Completion
Jun 1, 2029

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Transplant and Cell Therapy Candidates and Recipients
    Participants that agree to take part in this study, the study staff will first verify your demographic information (such as age, sex, race, and so on). Participants will then be asked about social barriers to care, including but not limited to: * primary language and confidence speaking English * education level * employment history * health literacy * legal history * caregiver status and literacy

Primary Outcome Measure

Social Determinants of Health Questionnaire [ Time Frame: At 6, 12, 18, and 24 months post Transplant and Cell Therapy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Warren Fingrut, MD
832-387-8363
Warren Fingrut, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX